Tevogen Bio Holdings Inc. (TVGNW) Stock Ticker
Market factors today
Unlock the full TVGNW picture
About Tevogen Bio Holdings Inc.
Tevogen Bio Holdings Inc. is a clinical-stage biotechnology company focused on developing ready-to-use, precision T cell therapies. Their research and development efforts span virology, oncology, and neurological conditions. The company's flagship experimental treatment, TVGN 489, is a precision T cell product designed to meet the unmet needs of individuals severely affected by acute COVID-19, as well as a specific group of patients struggling with long COVID. Tevogen Bio Holdings Inc. is headquartered in Warren, New Jersey.
TVGNW stock facts
| Ticker symbol | TVGNW |
| Exchange | NASDAQ Capital Market |
| Sector | Healthcare |
| Industry | Biotechnology |
| Market cap | $13.5M |
| CEO | Ryan H. Saadi |
| Employees | 18 |
| Headquarters | Warren, NJ, US |
| IPO date | 2024-02-15 |
| Website | tevogen.com |
What you can see for TVGNW on Tickr
Live TVGNW price chart with overlays, the options chain, implied move, IV rank, options flow and Strategy Lab, financial statements and consensus estimates, analyst ratings, catalysts, news with AI scoring, and an AI chat that has read the TVGNW report.
Rankings
FAQ
What is the ticker symbol for Tevogen Bio Holdings Inc.?
The ticker symbol for Tevogen Bio Holdings Inc. is TVGNW, listed on the NASDAQ Capital Market.
What is TVGNW?
Tevogen Bio Holdings Inc. is a clinical-stage biotechnology company focused on developing ready-to-use, precision T cell therapies. Their research and development efforts span virology, oncology, and neurological conditions. The company's flagship experimental treatment, TVGN 489, is a precision T cell product designed to meet the unmet needs of individuals severely affected by acute COVID-19,…